# Bupivacaine for Benign Headache in the ED

> **NCT01785459** · PHASE2 · TERMINATED · sponsor: **Wake Forest University Health Sciences** · enrollment: 23 (actual)

## Conditions studied

- Benign Headache

## Interventions

- **DRUG:** 0.5% bupivacaine
- **DRUG:** Standard Care

## Key facts

- **NCT ID:** NCT01785459
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Unable to enroll adequate number of patients.
- **Last updated:** 2022-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01785459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01785459, "Bupivacaine for Benign Headache in the ED". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01785459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*